Skip to main content
. 2023 Mar 1;8(1):44–52. doi: 10.22540/JFSF-08-044

Figure 3.

Figure 3

Mechanisms of treatment in RA patients. Biologic DMARDs (bDMARDs), targeted synthetic DMARDs (tsDMARDs), conventional synthetic DMARDs (csDMARDs).